| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/28/2004 | CN1515581A Preparation method of ginkgo leaf extract |
| 07/28/2004 | CN1515571A Phenyl xanthine derivative |
| 07/28/2004 | CN1515567A New benzothiaheptylyin with ileal bile acid transfer and taurocholate absorption inhibitor activity |
| 07/28/2004 | CN1515554A Intermediate compound for producing 2-amino-6-(2-substituted-4-phenoxy) substituted pyridine compound |
| 07/28/2004 | CN1515553A Piperidine derivative crystal, midbody for preparation and preparing method |
| 07/28/2004 | CN1515551A 1,2-indane or indoline derivative |
| 07/28/2004 | CN1515548A Oxaminic acid used as thyroid gland receptor ligand and its derivative |
| 07/28/2004 | CN1515524A Method for extracting isoflavone, flavones and lactone from armenica sibirica leaf by adoptnig solvent method |
| 07/28/2004 | CN1515523A Method for extracting isoflavone, flavones and lactone from armeniaca sibirica leaf by adopting resin method |
| 07/28/2004 | CN1515311A Blood-lipid-reducing thrombolytic medicine |
| 07/28/2004 | CN1515310A Turmeria oil extract dripping pill, its preparation method and application |
| 07/28/2004 | CN1515303A Chinese medicine preparation for curing coronary heart disease and angina pectoris and its preparation method |
| 07/28/2004 | CN1515296A Chinese medicine compound dripping pill, its preparation method and application |
| 07/28/2004 | CN1515292A Tenderizing and detoxicating health-care cold tea and its preparation method |
| 07/28/2004 | CN1515287A Chinese medicine preparation for curing cardio-cerebral vascular diseases |
| 07/28/2004 | CN1515285A Oral liquor for curing cerebral hemorrhage and its preparation method by using leach |
| 07/28/2004 | CN1515284A Rongshuan jiannaokang thrombolytic |
| 07/28/2004 | CN1515276A Medicine for preventing restenosis after interventional therapy of coronary heart disease and/or curing coronary heart disease and its preparation method |
| 07/28/2004 | CN1515274A Medicine for curing coronary heart disease |
| 07/28/2004 | CN1515266A New medicine for preventing and curing angiocardiopathy and its preparation method |
| 07/28/2004 | CN1515264A Breviscapine slowly-releasin tablet and its preparation method |
| 07/28/2004 | CN1515261A Topical medicine composite containing cholinergic drug or calcium channel paralyser |
| 07/28/2004 | CN1515260A Cinnarizine powder injection containing HPCD, its solid preparation and preparation method |
| 07/28/2004 | CN1515259A 4-aminosubstituted-2-substituted-1,2,3,4-tetrahydroquinoline used as CETP inhibitor |
| 07/28/2004 | CN1515252A Application of indole derivative as SHTI excitomotor |
| 07/28/2004 | CN1515251A Composition with function of beautifying face and its application |
| 07/28/2004 | CN1515248A Urea derivative used as inosine-5'-dehydrogenase monophosphate inhibitor |
| 07/28/2004 | CN1159445C Recombinant adevovirus for tissue specifie expression in heart |
| 07/28/2004 | CN1159318C Metal protease inhibitor, preparing process thereof and pharmaceutical composition contg. same |
| 07/28/2004 | CN1159316C Iso-Indolo-indolone compound, their preparation methods and drug compositions comprising the same |
| 07/28/2004 | CN1159314C Thiazolidinedione derivs. as antidiabetic agents |
| 07/28/2004 | CN1159295C Inhibitors of metalloproteinases |
| 07/28/2004 | CN1159289C C-terminal modified oxamyl dipetides as inhibitors of the ICE/ced-3 family of cystenine proteases |
| 07/28/2004 | CN1159061C Treatment of infarcts through inhibition of NF-KAPPAB |
| 07/28/2004 | CN1159037C Medicine for treating apoplexy |
| 07/28/2004 | CN1159030C Capsule for curing varicosis and its preparing method |
| 07/28/2004 | CN1159022C Ginkgo leaves composition and preparation method and uses |
| 07/28/2004 | CN1159019C Extractable compounds and method for making and using the same |
| 07/28/2004 | CN1159014C Use of 4 alpha-methyl-17 alpha-ethyle-estrane derivative for treatment of atherosclerosis |
| 07/28/2004 | CN1159010C Pharmaceutical composition comprising ticlopidine and ginkgo biloba extract |
| 07/28/2004 | CN1159000C Buccal delivery system |
| 07/27/2004 | US6767990 Peptides used as angiotensin converting enzyme inhibitor and preparation process thereof |
| 07/27/2004 | US6767921 Polymorphic forms of fasidotril, their methods of preparation and pharmaceutical compositions comprising them |
| 07/27/2004 | US6767917 Diuretics; cardiovascular, kidney and brain disorder treatment; antitumor, antiallergen, and antiasthmatic agents |
| 07/27/2004 | US6767910 Triazolo[4,5-d]pyrimidinyl compounds |
| 07/27/2004 | US6767909 Cardiovascular disorders; vasoconstriction |
| 07/27/2004 | US6767908 Treatment of cytokine mediated diseases such as arthritis. |
| 07/27/2004 | US6767907 For therapy of psychic and neurologic disorders |
| 07/27/2004 | US6767743 Method and an apparatus for generating shockwave, a method and an apparatus for accelerating particles, an apparatus for delivering drugs, and a method and an apparatus for delivering DNA |
| 07/27/2004 | US6767736 Human ion channel protein and polynucleotides encoding the same |
| 07/27/2004 | US6767565 Recovering lignans from plants; obtain plant biomass, expose to extraction solvent, separate solid plant material, remove microorganism from extraction solution, recover lignan |
| 07/27/2004 | US6767556 Hypotensive agents |
| 07/27/2004 | US6767554 Use of complexes among cationic liposomes and polydeoxyribonucleotides and medicaments |
| 07/27/2004 | US6767544 Methods for treating cardiovascular diseases with botulinum toxin |
| 07/27/2004 | CA2320233C Farnesyl transferase inhibitors having a piperidine structure and process for preparation thereof |
| 07/27/2004 | CA2129261C Processes of producing amylase inhibitors |
| 07/22/2004 | WO2004061073A2 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 07/22/2004 | WO2004060893A1 Pyrrolopyridine potassium channel openers |
| 07/22/2004 | WO2004060881A1 1,3-benzothiazinone derivatives, process for producing the same and use thereof |
| 07/22/2004 | WO2004060489A2 Treatment of chronic heart failure |
| 07/22/2004 | WO2004060395A1 Agent for improving life expectancy in therapy of malignant tumor |
| 07/22/2004 | WO2004060362A2 COMPOSITIONS AND METHODS FOR INHIBITING TGF-β |
| 07/22/2004 | WO2004060262A2 Modulators of notch signalling for use in immunotherpapy |
| 07/22/2004 | WO2004045591A3 Liquid pharmaceutical formulations containing 3,7-diazabicyclo`3,3,1! nonanes for treating anti-arrhythmic events |
| 07/22/2004 | WO2004039330A3 Compounds, methods and devices for inhibiting neoproliferative changes in blood vessel walls |
| 07/22/2004 | WO2004039313A3 Preventing desensitization of receptors |
| 07/22/2004 | WO2004024086A3 Compounds, compositions and methods |
| 07/22/2004 | WO2004002406A3 Bicyclic pyrimidinones as coagulation cascade inhibitors |
| 07/22/2004 | WO2003103743A3 Medical device for intra-lumenal delivery of pharmaceutical agents |
| 07/22/2004 | WO2003103583A8 A method for using tethered bis(polyhydroxyphenyls) and o-alkyl derivatives thereof in treating inflammatory conditions of the central nervous system |
| 07/22/2004 | WO2003087304A3 Tri-substituted heteroaryls and methods of making and using the same |
| 07/22/2004 | WO2003087086A3 Substituted indoles |
| 07/22/2004 | WO2003076426A3 Pyridinyloxy derivatives as 5-ht receptor ligands |
| 07/22/2004 | WO2003074560A3 Critical hypoxia-inducible factor-1alpha residues, products and methods related thereto |
| 07/22/2004 | WO2003072135A3 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors |
| 07/22/2004 | WO2003070675A3 Substituted 10-aryl-11h-benzo[b]fluorenes and 7-aryl-5,6-dihydro-benzo[a]anthracenes for selective effects on estrogen receptors |
| 07/22/2004 | WO2003059293A3 17-hydroxy-4-aza-androstan-3-ones as androgen receptor modulators |
| 07/22/2004 | WO2003044014A8 Indole-2-carboxamides as factor xa inhibitors |
| 07/22/2004 | WO2003017919A3 Composition comprising wenguanguo extracts, methods for preparing same and uses therof |
| 07/22/2004 | WO2003014299A3 SPHKs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 07/22/2004 | WO2003006002A9 Compositions and methods of administering tubulin binding agents for the treatment of ocular diseases |
| 07/22/2004 | WO2002088090A3 Pyrazole derived kinase inhibitors |
| 07/22/2004 | US20040143115 e.g., 1-[2-Benzoxazol-2-ylaminomethyl)-piperidin-1-yl]-1-(2-methyl-5phenyl-thiazol4-yl)-methanone; used to treat disorders where an antagonist of a human orexin receptor is required |
| 07/22/2004 | US20040143095 for treating high body temperature, appetite dysfunction, congestive heart failure, vascular disease, stress and anxiety; angiogenesis inhibitors; genetic engineering |
| 07/22/2004 | US20040143014 Therapeutic use of alpha-2-delta ligands |
| 07/22/2004 | US20040143008 Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms |
| 07/22/2004 | US20040143006 Peroxisome proliferator activator; antidiabetic agents; insulin resistance; |
| 07/22/2004 | US20040143003 Cyclopropylindole derivatives as selective serotonin reuptake inhibitors |
| 07/22/2004 | US20040143000 3,7-diazabicyclo [3.3.1] formulations as antiarhythmic compounds |
| 07/22/2004 | US20040142996 Peripherally-selective inhibitors of dopamine-beta-hydroxylase and method of their preparation |
| 07/22/2004 | US20040142982 Urea derivatives as integrin alpha 4 antagonists |
| 07/22/2004 | US20040142979 Cardiovascular disorders; respiratory system disorders; kidneys; liver diosrders; central nervous system diosrders; osteoarthritis; antiarthritic agents; antitumor agents; multiple sclerosis |
| 07/22/2004 | US20040142976 Modulation cytokine sensitive diseases, cellular adhesion molecules; Aids therapy; antihistamines; antiarthritic agents; bone disorders; malaria; cachexia; Crohn's disease |
| 07/22/2004 | US20040142972 Sleep disorders; side effect reduction ; antihistamine antagonist |
| 07/22/2004 | US20040142963 Cardiovascular disorders |
| 07/22/2004 | US20040142961 Utilization of substituted imidazo[1,2-a]-pyridine compounds in pharmaceutical formulations |
| 07/22/2004 | US20040142952 Triazoloquinazoline and pyrazolotriazolopyrimidine derivatives, medicinal compositions, adenosine a3 receptor affinity agents, ocular tension lowering agents, preparations for preventing and treating glaucoma and method of lowering ocular tension |
| 07/22/2004 | US20040142950 Amide and ester matrix metalloproteinase inhibitors |
| 07/22/2004 | US20040142947 Pyrrolopyrimidines |
| 07/22/2004 | US20040142945 Antiarthritic agents; multiple sclerosis ; organ rejection ; antidiabetic agents; inflammatory bowel disorders; antiischemic agents; skin disorders |